Therapeutic targeting of ribosome biogenesis in cancer and ribosomopathies
Researchers
- Professor Ross Hannan (Primary Investigator)
Grant status
CompletedGrant start date
01/01/2017Grant funding
- 2017: $152,769 from National Health and Medical Research Council (NHMRC)
- 2018: $152,769 from National Health and Medical Research Council (NHMRC)
- 2019: $152,769 from National Health and Medical Research Council (NHMRC)
- 2020: $152,769 from National Health and Medical Research Council (NHMRC)
- 2021: $152,769 from National Health and Medical Research Council (NHMRC)